In announcing its $42.9 billion inversion deal with Covidien two years ago, Medtronic vowed to use some of its new financial flexibility to invest $10 billion in U.S. medical technology over the coming decade.
News & Features
We’re celebrating brilliant, budding minds in the medical technology field. These innovators, all under 30 years old, have racked up outsized achievements.
FDA cleared a new application designed to integrate ultrasound and angiography images to guide heart teams during structural heart procedures.
Less than a month after FDA alerted doctors of patient deaths related to balloon-based obesity procedures, a newer version of Apollo’s Orbera balloon has been approved in Europe.
MD+DI and Qmed are joining forces to become a one-stop shop for medtech news and supplier connections.
Teleflex agreed to pay up to $1.1 billion for NeoTract, a hyper-growth company in the urological device market.
ExThera Medical's new blood filter technology received Expedited Access Pathway (EAP) designation, accelerating the FDA approval process for the device ahead of clinical use.
Medtronic entered the next phase of its partnership with Mazor by putting up an additional $40 million equity investment and assuming the global distribution of the Mazor X robot. Analysts say the deal is positive for both companies but negative for competitors like NuVasive that lack a robotics system.
Here’s what was new in the world of medical device suppliers during the week of August 27. This is a compilation of the latest news from suppliers in the medical device industry. If you have news you’d like to submit for potential inclusion in this weekly roundup, please send a press release and...
Qmed is joining forces with MD+DI to become a one-stop shop to keep you up to date on the latest medtech news and connect you with suppliers and service providers. Qmed has been connecting you with medtech suppliers and keeping you informed about the latest industry news since 2010, and now your...